Review



deferoxamine dfo  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    MedChemExpress deferoxamine dfo
    Deferoxamine Dfo, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 157 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/deferoxamine dfo/product/MedChemExpress
    Average 96 stars, based on 157 article reviews
    deferoxamine dfo - by Bioz Stars, 2026-04
    96/100 stars

    Images



    Similar Products

    96
    MedChemExpress deferoxamine dfo
    Deferoxamine Dfo, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/deferoxamine dfo/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    deferoxamine dfo - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    94
    TargetMol dfo
    Dfo, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dfo/product/TargetMol
    Average 94 stars, based on 1 article reviews
    dfo - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    96
    MedChemExpress deferoxamine mesylate dfo
    Deferoxamine Mesylate Dfo, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/deferoxamine mesylate dfo/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    deferoxamine mesylate dfo - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    96
    MedChemExpress deferoxamine
    Deferoxamine, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/deferoxamine/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    deferoxamine - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    96
    MedChemExpress dfo treated group
    Liver function of rats with chronic cholestasis is impaired and histopathological analysis of liver tissue reveals inflammation. The control group was fed a chow diet, and the ANIT <t>and</t> <t>DFO-treated</t> groups were intragastrically administered ANIT olive oil solution with or without DFO (n=8/group). (A) TBA, (B) ALP, (C) TBIL, (D) DBIL, (E) GGT, (F) LDL, (G) TCH, (H) TG, (I) ALT and (J) AST were measured. **P<0.01, ***P<0.001. (K) Hematoxylin and eosin staining (scale bar, 200 µm). Arrows indicate bile duct hyperplasia and inflammatory cell infiltration in the portal area. ANIT, α-naphthyl isothiocyanate; DFO, deferoxamine; TBA, total bile acid; ALP, alkaline phosphatase; TBIL, total bilirubin; DBIL, direct bilirubin; GGT, γ-glutamyl transferase; LDL, low-density lipoprotein; TCH, total cholesterol; TG, triglyceride; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
    Dfo Treated Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dfo treated group/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    dfo treated group - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    95
    MedChemExpress dfo treatment
    Liver function of rats with chronic cholestasis is impaired and histopathological analysis of liver tissue reveals inflammation. The control group was fed a chow diet, and the ANIT <t>and</t> <t>DFO-treated</t> groups were intragastrically administered ANIT olive oil solution with or without DFO (n=8/group). (A) TBA, (B) ALP, (C) TBIL, (D) DBIL, (E) GGT, (F) LDL, (G) TCH, (H) TG, (I) ALT and (J) AST were measured. **P<0.01, ***P<0.001. (K) Hematoxylin and eosin staining (scale bar, 200 µm). Arrows indicate bile duct hyperplasia and inflammatory cell infiltration in the portal area. ANIT, α-naphthyl isothiocyanate; DFO, deferoxamine; TBA, total bile acid; ALP, alkaline phosphatase; TBIL, total bilirubin; DBIL, direct bilirubin; GGT, γ-glutamyl transferase; LDL, low-density lipoprotein; TCH, total cholesterol; TG, triglyceride; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
    Dfo Treatment, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dfo treatment/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    dfo treatment - by Bioz Stars, 2026-04
    95/100 stars
      Buy from Supplier

    95
    MedChemExpress dfo
    Liver function of rats with chronic cholestasis is impaired and histopathological analysis of liver tissue reveals inflammation. The control group was fed a chow diet, and the ANIT <t>and</t> <t>DFO-treated</t> groups were intragastrically administered ANIT olive oil solution with or without DFO (n=8/group). (A) TBA, (B) ALP, (C) TBIL, (D) DBIL, (E) GGT, (F) LDL, (G) TCH, (H) TG, (I) ALT and (J) AST were measured. **P<0.01, ***P<0.001. (K) Hematoxylin and eosin staining (scale bar, 200 µm). Arrows indicate bile duct hyperplasia and inflammatory cell infiltration in the portal area. ANIT, α-naphthyl isothiocyanate; DFO, deferoxamine; TBA, total bile acid; ALP, alkaline phosphatase; TBIL, total bilirubin; DBIL, direct bilirubin; GGT, γ-glutamyl transferase; LDL, low-density lipoprotein; TCH, total cholesterol; TG, triglyceride; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
    Dfo, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dfo/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    dfo - by Bioz Stars, 2026-04
    95/100 stars
      Buy from Supplier

    Image Search Results


    Liver function of rats with chronic cholestasis is impaired and histopathological analysis of liver tissue reveals inflammation. The control group was fed a chow diet, and the ANIT and DFO-treated groups were intragastrically administered ANIT olive oil solution with or without DFO (n=8/group). (A) TBA, (B) ALP, (C) TBIL, (D) DBIL, (E) GGT, (F) LDL, (G) TCH, (H) TG, (I) ALT and (J) AST were measured. **P<0.01, ***P<0.001. (K) Hematoxylin and eosin staining (scale bar, 200 µm). Arrows indicate bile duct hyperplasia and inflammatory cell infiltration in the portal area. ANIT, α-naphthyl isothiocyanate; DFO, deferoxamine; TBA, total bile acid; ALP, alkaline phosphatase; TBIL, total bilirubin; DBIL, direct bilirubin; GGT, γ-glutamyl transferase; LDL, low-density lipoprotein; TCH, total cholesterol; TG, triglyceride; ALT, alanine aminotransferase; AST, aspartate aminotransferase.

    Journal: Molecular Medicine Reports

    Article Title: Pathological mechanism of ferroptosis in a rat model of α-naphthyl isothiocyanate-induced chronic cholestasis

    doi: 10.3892/mmr.2026.13802

    Figure Lengend Snippet: Liver function of rats with chronic cholestasis is impaired and histopathological analysis of liver tissue reveals inflammation. The control group was fed a chow diet, and the ANIT and DFO-treated groups were intragastrically administered ANIT olive oil solution with or without DFO (n=8/group). (A) TBA, (B) ALP, (C) TBIL, (D) DBIL, (E) GGT, (F) LDL, (G) TCH, (H) TG, (I) ALT and (J) AST were measured. **P<0.01, ***P<0.001. (K) Hematoxylin and eosin staining (scale bar, 200 µm). Arrows indicate bile duct hyperplasia and inflammatory cell infiltration in the portal area. ANIT, α-naphthyl isothiocyanate; DFO, deferoxamine; TBA, total bile acid; ALP, alkaline phosphatase; TBIL, total bilirubin; DBIL, direct bilirubin; GGT, γ-glutamyl transferase; LDL, low-density lipoprotein; TCH, total cholesterol; TG, triglyceride; ALT, alanine aminotransferase; AST, aspartate aminotransferase.

    Article Snippet: The DFO-treated group received daily DFO treatment (MedChemExpress; 100 mg/kg) ( ) for 4 weeks (weeks 9–12).

    Techniques: Control, Staining

    Intrahepatic collagen fiber deposition is increased in rats with chronic cholestasis. Control group was fed a chow diet, whereas ANIT and DFO-treated groups were intragastrically administered ANIT olive oil solution with or without DFO (n=8/group). (A) Sirius red staining (scale bar, 200 µ m) and (B) collagen-positive area in the liver. (C) HYP levels in the liver. (D) Changes in α-SMA protein expression. The blots shown are representative of three independent experiments. The dotted line indicates that the lanes were non-adjacent on the original gel. (E) Relative expression levels of α-SMA. Results Data are presented as the mean ± SD. P-values were determined by one-way ANOVA. *P<0.05, ***P<0.001. ANIT, α-naphthyl isothiocyanate; DFO, deferoxamine; HYP, hydroxyproline; α-SMA, α-smooth muscle actin.

    Journal: Molecular Medicine Reports

    Article Title: Pathological mechanism of ferroptosis in a rat model of α-naphthyl isothiocyanate-induced chronic cholestasis

    doi: 10.3892/mmr.2026.13802

    Figure Lengend Snippet: Intrahepatic collagen fiber deposition is increased in rats with chronic cholestasis. Control group was fed a chow diet, whereas ANIT and DFO-treated groups were intragastrically administered ANIT olive oil solution with or without DFO (n=8/group). (A) Sirius red staining (scale bar, 200 µ m) and (B) collagen-positive area in the liver. (C) HYP levels in the liver. (D) Changes in α-SMA protein expression. The blots shown are representative of three independent experiments. The dotted line indicates that the lanes were non-adjacent on the original gel. (E) Relative expression levels of α-SMA. Results Data are presented as the mean ± SD. P-values were determined by one-way ANOVA. *P<0.05, ***P<0.001. ANIT, α-naphthyl isothiocyanate; DFO, deferoxamine; HYP, hydroxyproline; α-SMA, α-smooth muscle actin.

    Article Snippet: The DFO-treated group received daily DFO treatment (MedChemExpress; 100 mg/kg) ( ) for 4 weeks (weeks 9–12).

    Techniques: Control, Staining, Expressing

    Free iron ions are aberrantly increased in serum and liver samples from rats with chronic cholestasis. Control group was fed a chow diet, whereas ANIT and DFO-treated groups were intragastrically administered ANIT olive oil solution with or without DFO (n=8/group). (A) Serum iron, (B) liver iron and (C) liver Fe 2+ levels were detected. (D) Liver Prussian blue Fe 3+ positive area. Data are presented as the mean ± SD. P-values were determined by one-way ANOVA. *P<0.05, **P<0.01, ***P<0.001. (E) Prussian blue staining (scale bar, 200 µ m). ANIT, α-naphthyl isothiocyanate; DFO, deferoxamine.

    Journal: Molecular Medicine Reports

    Article Title: Pathological mechanism of ferroptosis in a rat model of α-naphthyl isothiocyanate-induced chronic cholestasis

    doi: 10.3892/mmr.2026.13802

    Figure Lengend Snippet: Free iron ions are aberrantly increased in serum and liver samples from rats with chronic cholestasis. Control group was fed a chow diet, whereas ANIT and DFO-treated groups were intragastrically administered ANIT olive oil solution with or without DFO (n=8/group). (A) Serum iron, (B) liver iron and (C) liver Fe 2+ levels were detected. (D) Liver Prussian blue Fe 3+ positive area. Data are presented as the mean ± SD. P-values were determined by one-way ANOVA. *P<0.05, **P<0.01, ***P<0.001. (E) Prussian blue staining (scale bar, 200 µ m). ANIT, α-naphthyl isothiocyanate; DFO, deferoxamine.

    Article Snippet: The DFO-treated group received daily DFO treatment (MedChemExpress; 100 mg/kg) ( ) for 4 weeks (weeks 9–12).

    Techniques: Control, Staining

    Levels of lipid peroxidation and ferroptosis markers are increased in the liver of rats with chronic cholestasis and the liver ultrastructure is affected in a DFO-reversible manner. Control group was fed a chow diet, whereas ANIT and DFO-treated groups were intragastrically administered ANIT olive oil solution with or without DFO (n=8/group). Levels of (A) MDA, (B) GSH and (C) GSH-PX were detected. (D) Changes in ferroptosis marker protein expression. The blots shown are representative of three independent experiments. A dotted line indicates that the lanes were non-adjacent on the original gel. All target protein bands and their corresponding loading control bands shown side-by-side were derived from the same membrane. Relative expression levels of (E) ASCL4 and (F) COX2. Data are presented as the mean ± SD. P-values were determined by one-way ANOVA. *P<0.05, **P<0.01, ***P<0.001. (G) Transmission electron microscope sections, blue arrows indicate mitochondrial cristae, yellow arrows indicate outer mitochondrial membrane and green arrows point to mitochondria (scale bars, 5 and 2 µ m). DFO, deferoxamine; ANIT, α-naphthyl isothiocyanate; MDA, malondialdehyde; GSH, glutathione; GSH-PX, glutathione peroxidase; ASCL4, acyl-CoA synthetase long-chain family member 4; COX2, cyclooxygenase 2.

    Journal: Molecular Medicine Reports

    Article Title: Pathological mechanism of ferroptosis in a rat model of α-naphthyl isothiocyanate-induced chronic cholestasis

    doi: 10.3892/mmr.2026.13802

    Figure Lengend Snippet: Levels of lipid peroxidation and ferroptosis markers are increased in the liver of rats with chronic cholestasis and the liver ultrastructure is affected in a DFO-reversible manner. Control group was fed a chow diet, whereas ANIT and DFO-treated groups were intragastrically administered ANIT olive oil solution with or without DFO (n=8/group). Levels of (A) MDA, (B) GSH and (C) GSH-PX were detected. (D) Changes in ferroptosis marker protein expression. The blots shown are representative of three independent experiments. A dotted line indicates that the lanes were non-adjacent on the original gel. All target protein bands and their corresponding loading control bands shown side-by-side were derived from the same membrane. Relative expression levels of (E) ASCL4 and (F) COX2. Data are presented as the mean ± SD. P-values were determined by one-way ANOVA. *P<0.05, **P<0.01, ***P<0.001. (G) Transmission electron microscope sections, blue arrows indicate mitochondrial cristae, yellow arrows indicate outer mitochondrial membrane and green arrows point to mitochondria (scale bars, 5 and 2 µ m). DFO, deferoxamine; ANIT, α-naphthyl isothiocyanate; MDA, malondialdehyde; GSH, glutathione; GSH-PX, glutathione peroxidase; ASCL4, acyl-CoA synthetase long-chain family member 4; COX2, cyclooxygenase 2.

    Article Snippet: The DFO-treated group received daily DFO treatment (MedChemExpress; 100 mg/kg) ( ) for 4 weeks (weeks 9–12).

    Techniques: Control, Marker, Expressing, Derivative Assay, Membrane, Transmission Assay, Microscopy

    Abnormal expression of antioxidant and iron metabolism-related proteins in liver samples of rats with chronic cholestasis. Control group was fed a chow diet, whereas the ANIT and DFO-treated groups were intragastrically administered ANIT olive oil solution with or without DFO (n=8/group). (A) Changes in ferroptosis antioxidant-related protein expression. The blots shown are representative of three independent experiments. A dotted line indicates that the lanes were non-adjacent on the original gel. All target protein bands and their corresponding loading control bands shown side-by-side were derived from the same membrane. Relative expression levels of (B) Nrf2, (C) Keap1, (D) XCT, (E) HO-1 and (F) GPX4. (G) Changes in iron metabolism-related protein expression. The blots shown are representative of three independent experiments. A dotted line indicates that the lanes were non-adjacent on the original gel. All target protein bands and their corresponding loading control bands shown side-by-side were derived from the same membrane. Relative expression levels of (H) TFR1, (I) FPN1, (J) DMT1, (K) Steap3 and (L) FTH1. Data are presented as the mean ± SD. P-values were determined by one-way ANOVA. *P<0.05, **P<0.01, ***P<0.001. ANIT, α-naphthyl isothiocyanate; DFO, deferoxamine; Nrf2, nuclear factor erythroid-2-related factor 2; Keap1, Kelch-like ECH-associated protein 1, XCT, cystine/glutamate transporter; HO-1, heme oxygenase 1; GPX4, glutathione peroxidase 4; TFR1, transferrin receptor 1; FPN1, ferroportin 1; DMT1, divalent metal transporter 1; Steap3, six-transmembrane epithelial antigen of the prostate 3; FTH1, ferritin heavy chain 1.

    Journal: Molecular Medicine Reports

    Article Title: Pathological mechanism of ferroptosis in a rat model of α-naphthyl isothiocyanate-induced chronic cholestasis

    doi: 10.3892/mmr.2026.13802

    Figure Lengend Snippet: Abnormal expression of antioxidant and iron metabolism-related proteins in liver samples of rats with chronic cholestasis. Control group was fed a chow diet, whereas the ANIT and DFO-treated groups were intragastrically administered ANIT olive oil solution with or without DFO (n=8/group). (A) Changes in ferroptosis antioxidant-related protein expression. The blots shown are representative of three independent experiments. A dotted line indicates that the lanes were non-adjacent on the original gel. All target protein bands and their corresponding loading control bands shown side-by-side were derived from the same membrane. Relative expression levels of (B) Nrf2, (C) Keap1, (D) XCT, (E) HO-1 and (F) GPX4. (G) Changes in iron metabolism-related protein expression. The blots shown are representative of three independent experiments. A dotted line indicates that the lanes were non-adjacent on the original gel. All target protein bands and their corresponding loading control bands shown side-by-side were derived from the same membrane. Relative expression levels of (H) TFR1, (I) FPN1, (J) DMT1, (K) Steap3 and (L) FTH1. Data are presented as the mean ± SD. P-values were determined by one-way ANOVA. *P<0.05, **P<0.01, ***P<0.001. ANIT, α-naphthyl isothiocyanate; DFO, deferoxamine; Nrf2, nuclear factor erythroid-2-related factor 2; Keap1, Kelch-like ECH-associated protein 1, XCT, cystine/glutamate transporter; HO-1, heme oxygenase 1; GPX4, glutathione peroxidase 4; TFR1, transferrin receptor 1; FPN1, ferroportin 1; DMT1, divalent metal transporter 1; Steap3, six-transmembrane epithelial antigen of the prostate 3; FTH1, ferritin heavy chain 1.

    Article Snippet: The DFO-treated group received daily DFO treatment (MedChemExpress; 100 mg/kg) ( ) for 4 weeks (weeks 9–12).

    Techniques: Expressing, Control, Derivative Assay, Membrane